Increased formation of angiotensin II from angiotensin I in individuals of African descent
- PMID: 40509687
- DOI: 10.1097/HJH.0000000000004068
Increased formation of angiotensin II from angiotensin I in individuals of African descent
Abstract
Objective: Activation of the renin-angiotensin-aldosterone system (RAAS) and African ancestry are both associated with increased end-organ damage in hypertension. An insertion (I)/deletion (D) polymorphism in the gene encoding the angiotensin-converting enzyme (ACE) has been associated with ACE activity. This study tested the hypothesis that ancestry or ACE I/D genotype affects the conversion of angiotensin (Ang) I to Ang II and blood pressure, renal plasma flow, and aldosterone during Ang I or II infusion.
Methods: Ang I and Ang II were infused in graded doses from 1 to 20 ng/kg/min in a randomized, single-blind, crossover study in salt-replete normotensive participants of self-identified African (Black) or European (white) ancestry who were homozygous for the ACE I/I (7 Black, 8 white) or D/D (8 Black, 8 white) genotype.
Results: ACE activity was significantly increased in ACE D/D vs. ACE I/I individuals regardless of ancestry. The conversion of Ang I to Ang II was increased in Black compared to in white participants, independent of genotype. The pressor and aldosterone responses to Ang I and Ang II did not differ by ancestry or ACE I/D genotype. Basal renal plasma flow was increased in individuals of ACE D/D genotype independent of ancestry but the renal vasoconstrictor response to Ang I and Ang II did not differ by ACE genotype.
Conclusions: The conversion of infused Ang I to Ang II is increased in Black compared to in white individuals. Increased Ang II could contribute to attenuated responses to RAAS interfering drugs and end-organ damage in individuals of African ancestry.
Keywords: aldosterone; ancestry; angiotensin; angiotensin-converting enzyme; blood pressure; renal blood flow; renin.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Gandhi SK, Gainer J, King D, Brown NJ. Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension 1998; 31:90–96.
-
- Brown NJ, Blais C, Gandhi SK, Adam A. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharm 1998; 32:373–377.
-
- Claggett B, Packer M, McMurray JJ, Swedberg K, Rouleau J, Zile MR, et al. Estimating the long-term treatment benefits of sacubitril-valsartan. N Engl J Med 2015; 373:2289–2290.
-
- Touyz RM. Silencing angiotensinogen in hypertension. N Engl J Med 2023; 389:278–281.
-
- Freeman MW, Halvorsen YD, Marshall W, Pater M, Isaacsohn J, Pearce C, et al. Phase 2 Trial of baxdrostat for treatment-resistant hypertension. N Engl J Med 2023; 388:395–405.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous